BioCentury
ARTICLE | Financial News

ImmunoCellular amends follow-on

July 18, 2016 7:00 AM UTC

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2016-07-11 Type: Follow-on To be raised: Up to $24.2 million Shares: 60 million Price Prior: $0.27 Un...